324 related articles for article (PubMed ID: 27553515)
21. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.
Takizawa H; Kondo K; Matsuoka H; Uyama K; Toba H; Kenzaki K; Sakiyama S; Tangoku A; Miura K; Yoshizawa K; Morita J
J Med Invest; 2008 Feb; 55(1-2):37-43. PubMed ID: 18319543
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
[TBL] [Abstract][Full Text] [Related]
23. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
24. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
25. Lymph node sampling in lung cancer: how should it be done?
Naruke T; Tsuchiya R; Kondo H; Nakayama H; Asamura H
Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S17-24. PubMed ID: 10536940
[TBL] [Abstract][Full Text] [Related]
26. Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients.
Bu J; Pang S; Kong X; Liu B; Xiao Q; Qu C
J Cardiothorac Surg; 2024 Jun; 19(1):357. PubMed ID: 38910251
[TBL] [Abstract][Full Text] [Related]
27. Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer.
Park JS; Yang HC; Kim HK; Kim K; Shim YM; Choi YS; Kim J
J Thorac Oncol; 2010 Apr; 5(4):517-20. PubMed ID: 20104190
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
29. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial.
Palade E; Passlick B; Osei-Agyemang T; Günter J; Wiesemann S
Eur J Cardiothorac Surg; 2013 Aug; 44(2):244-9; discussion 249. PubMed ID: 23295451
[TBL] [Abstract][Full Text] [Related]
30. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
32. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
[TBL] [Abstract][Full Text] [Related]
34. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer.
Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
Jpn J Clin Oncol; 2023 Dec; 53(12):1183-1190. PubMed ID: 37622593
[TBL] [Abstract][Full Text] [Related]
35. Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case-control study.
Steinfort DP; Tsui A; Grieve J; Hibbs ML; Anderson GP; Irving LB
Hum Pathol; 2012 Mar; 43(3):333-8. PubMed ID: 21835432
[TBL] [Abstract][Full Text] [Related]
36. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
37. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
Fukui T; Mori S; Yokoi K; Mitsudomi T
J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
[TBL] [Abstract][Full Text] [Related]
38. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
[TBL] [Abstract][Full Text] [Related]
39. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
Robinson BM; Kennedy C; McLean J; McCaughan BC
J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
[TBL] [Abstract][Full Text] [Related]
40. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
